Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H32Br2Cl2N2O3 |
InChIKeyINKLAKXQHDQKKZ-UHFFFAOYSA-N |
CAS Registry118372-34-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 22 Nov 2006 | |
Neoplasms | Preclinical | US | 22 Nov 2006 |